These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1330385)

  • 1. Plasma 19-hydroxy-androstenedione (19-OH-A) in essential hypertension.
    Tosti-Croce C; Rinaldi R; Massaria M; Lomurno A; Felicioli T; Sciarra F
    Clin Exp Hypertens A; 1992; 14(6):1083-94. PubMed ID: 1330385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
    Sekihara H; Torii R; Osawa Y; Takaku F
    J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension.
    Sekihara H; Yonemitsu K; Yazaki Y
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):557-60. PubMed ID: 8252745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma catecholamines and the renin-aldosterone system during exercise in normal and essential hypertensive subjects.
    Jindra A; Savliková J; Bultas J
    Clin Exp Hypertens A; 1990; 12(3):415-35. PubMed ID: 2192824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma 19-hydroxyandrostenedione levels in patients with aldosterone-producing adenoma.
    Morita H; Mune T; Yasuda K; Yamakita N; Miyazaki S; Miura K
    Endocr J; 1993 Feb; 40(1):89-97. PubMed ID: 7951501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ACTH on plasma levels of adrenal steroids in essential hypertension.
    Honda M
    Endocrinol Jpn; 1976 Jun; 23(3):195-202. PubMed ID: 186257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
    Sekihara H
    J Steroid Biochem; 1983 Jul; 19(1A):353-8. PubMed ID: 6310235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of aldosterone and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterial hypertension].
    Tosti-Croce C; Graziosi S; Giaquinto G; Sparano F; Sciarra F
    Minerva Med; 1981 Mar; 72(9):575-80. PubMed ID: 6264356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of plasma ACTH and adrenocortical hormones to potassium loading in essential hypertension.
    Ueda Y; Honda M; Tsuchiya M; Watanabe H; Izumi Y; Shiratsuchi T; Inoue T; Hatano M
    Jpn Circ J; 1982 Apr; 46(4):317-22. PubMed ID: 6283190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma catecholamine responses during a personalized physical stress as a dynamic characterization of essential hypertension.
    Tosti-Croce C; Lucarelli C; Betto P; Floridi A; Rinaldi R; Salvati A; Taggi F; Sciarra F
    Physiol Behav; 1991 Apr; 49(4):685-90. PubMed ID: 1881970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-human atrial natriuretic polypeptide inhibits 19-hydroxy-androstenedione secretion by human adrenal cells.
    Higuchi K; Nawata H; Kato K; Ibayashi H
    Horm Metab Res; 1989 Feb; 21(2):92-5. PubMed ID: 2542147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19-hydroxyandrostenedione, a new amplifier of the action of aldosterone, in low renin essential hypertension.
    Sekihara H; Ohsawa N
    Jpn J Med; 1982 Apr; 21(2):154-5. PubMed ID: 6288988
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretory regulation of 19-hydroxyandrostenedione in normal man.
    Morita H; Mune T; Yasuda K; Mercado-Asis LB; Murayama M; Yamakita N; Miyazaki S; Miura K
    Endocrinol Jpn; 1992 Oct; 39(5):431-8. PubMed ID: 1478184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent.
    Sekihara H
    Clin Exp Hypertens A; 1983; 5(1):1-9. PubMed ID: 6339119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients.
    Manhem P; Bramnert M; Hulthén UL; Hökfelt B
    Eur J Clin Invest; 1981 Oct; 11(5):389-95. PubMed ID: 6800810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
    Williams GH; Braley LM; Underwood RH
    J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.